Matthew Kalady, MD, comments on a recent study that found that NCCN-recommended rectal cancer treatment has a much lower rate of effectiveness in patients under 50 years old.
New Study Enables a Dynamic View of Cancer-free Survival Rates for Rectal Cancer Patients Treated with Chemoradiation and Surgery
A new study presented at ASCRS 2018 helps clinicians give rectal cancer patients treated with chemoradiation and surgery a clearer picture of what they can expect to plan their futures.
Developing the National Accreditation Program for Rectal Cancer
Two Cleveland Clinic physicians played instrumental roles in the development of new standards for a multidisciplinary approach to rectal cancer care.
Statins Inhibit In Vitro Growth and Increase Radiation Sensitivity of Colorectal Cancer Cells
Researchers found that simvastatin combined with radiation inhibited the growth of CRC cells in vitro and increased their radiation sensitivity in a dose-dependent manner.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New Study Supports Flexible Sigmoidoscopy Protocol for Colorectal Cancer Screening in Those Under Age 50
James Church, MD, explains new research recommending flexible sigmoidoscopy screening beginning at age 40 in average-risk individuals, based on the steadily upsurging incidence of early-onset colorectal cancer and the left-sided predominance of CRC in these patients,
New Findings: Influence of High-Fat Diet on Colorectal Cancer
Cleveland Clinic researchers have identified a specific molecular pathway that plays a key role in the link between a high-fat diet and tumor growth in the colon.
Rectal Cancer Discoveries Show Promise for Predicting Neoadjuvant Responders
CAFs present in the rectal tumor microenvironment, when treated with radiation, increase the secretion of factors that contribute to tumor growth and cell migration. What this finding means for future treatment.
Multigene Panel Testing Reveals Mutations in Early Onset CRC Patients
A new study is the first using multigene panel testing to examine potentially important mutations among patients with early-onset colorectal cancer. Here’s how it suggests screening should change.
Physician Collaboration Helps Design Ideal Patient Experience at New Cancer Building
Several surgeons, physicians and specialists helped design Cleveland Clinic’s new cancer building, creating an environment for efficient treatment and care for patients.
Jagelman Registries for Hereditary Colorectal Cancer Syndromes Prove Their Value Long-Term
By following multiple generations of families affected by hereditary colorectal cancer syndromes, Cleveland Clinic’s Jagelman Registries are preventing cancer mortality in the third generation.